Pharmaceutical compositions and methods of inhibiting angiogenesis using naaladase inhibitors
    6.
    发明授权
    Pharmaceutical compositions and methods of inhibiting angiogenesis using naaladase inhibitors 失效
    使用奈拉替酶抑制剂抑制血管生成的药物组合物和方法

    公开(公告)号:US06395718B1

    公开(公告)日:2002-05-28

    申请号:US09110262

    申请日:1998-07-06

    IPC分类号: A61K3166

    CPC分类号: C07C323/56 C07C323/52

    摘要: The present disclosure relates to a method of inhibiting angiogenesis comprising administering a N-Acetylated &agr;-Linked Acidic Dipeptidase (NAALADase) inhibitor to a patient in need thereof, and a pharmaceutical composition comprising an anti-angiogenic effective amount of a NAALADase inhibitor and a pharmaceutically acceptable carrier.

    摘要翻译: 本公开内容涉及抑制血管发生的方法,其包括向有需要的患者施用N-乙酰化的α-连接酸性二肽酶(NAALADase)抑制剂,以及包含抗血管生成有效量的NAALADase抑制剂和药物 可接受的载体

    Thio-substituted pentanedioic acid derivatives
    8.
    发明授权
    Thio-substituted pentanedioic acid derivatives 失效
    硫代取代戊二酸衍生物

    公开(公告)号:US06265609B1

    公开(公告)日:2001-07-24

    申请号:US09228391

    申请日:1999-01-12

    IPC分类号: C07C5502

    CPC分类号: C07C323/56 C07C323/52

    摘要: The present invention relate to thio-substituted pentanedioic acid derivatives that inhibit N-Acetylated &agr;-Linked Acidic Dipeptidase (NAALADase) enzyme activity, pharmaceutical compositions comprising the same, and methods of using the same to inhibit NAALADase enzyme activity, to effect neuronal activities, to inhibit angiogenesis, and to treat glutamate abnormalities, compulsive disorders and prostate diseases.

    摘要翻译: 本发明涉及抑制N-乙酰化α链接酸性二肽酶(NAALADase)酶活性的硫代取代戊二酸衍生物,包含其的药物组合物及其用于抑制NAALADase酶活性,影响神经元活性的方法, 抑制血管发生,并治疗谷氨酸异常,强迫症和前列腺疾病。